why choose us

First received: May 12, 2025

Clinical Trial: Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Long COVID

Study Type: INTERVENTIONAL


Official Title: Evaluation of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms: A Pragmatic, Interventional Clinical Study.

Brief Summary: This pragmatic clinical study aims to evaluate the efficacy and tolerance of a combined quercetin/curcumin supplement in adults experiencing mild to moderate symptoms of Long COVID-19.Participants will receive the combined quercetin/curcumin supplement for 2 months.The primary outcome is the improvement in overall symptom burden, while secondary outcomes include changes in quality of life, the need for NSAIDs, and inflammatory markers.The study seeks to provide real-world evidence of the potential…

Read more